Skip to main content

MetLife Value Stock - Dividend - Research Selection

Metlife

ISIN: US59156R1086 , WKN: 934623

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners\', and personal excess liability, as well as small business owners\' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Wells Fargo Maintains MetLife (MET) Overweight Recommendation

2025-11-08

UBS Maintains MetLife (MET) Buy Recommendation

2025-11-07

MetLife Inc (MET) Q3 2025 Earnings Call Highlights: Strong Earnings Growth and Robust ...

2025-11-06
MetLife Inc (MET) reports a 22% increase in adjusted earnings per share and returns $875 million to shareholders, despite facing tax challenges in Mexico.

Are Wall Street Analysts Predicting MetLife Stock Will Climb or Sink?

2025-11-06
While MetLife has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

MetLife Q3 Earnings Beat Estimates on Lower Costs, Asia Unit Strength

2025-11-06
MET beats Q3 EPS estimates and rose 21% year over year as strong Asia results, attributable to higher volumes, and lower expenses offset Latin America tax hit.

Life insurer Brighthouse agrees to $4.1bn takeover by Aquarian

2025-11-06
Private capital group Aquarian Holdings has struck a deal to take private one of the largest remaining independent US life insurers for $4.1bn...

MetLife, Inc. (MET) Q3 2025 Earnings Call Transcript

2025-11-06
MetLife, Inc. (MET) Q3 2025 Earnings Call November 6, 2025 9:00 AM ESTCompany ParticipantsJohn Hall - Senior VP & Head of Investor RelationsMichel...

MetLife, Inc. 2025 Q3 - Results - Earnings Call Presentation

2025-11-06
2025-11-06. The following slide deck was published by MetLife, Inc.

MetLife (MET) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

2025-11-05
While the top- and bottom-line numbers for MetLife (MET) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

MetLife (NYSE:MET) Misses Q3 Sales Expectations

2025-11-05
Global insurance giant MetLife (NYSE:MET) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 1.4% year on year to $17.36 billion. Its non-GAAP profit of $2.37 per share was 2.2% above analysts’ consensus estimates.